Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: October 10th 2024 | Updated: October 14th 2024
Key Highlights on POD1UM-303 Presented at ESMO 2024
Published: October 5th 2023 | Updated: October 14th 2024
FDA’s ODAC Votes No for Sotorasib in KRAS G12C-Mutated NSCLC
Published: January 2nd 2024 | Updated: October 14th 2024
FDA Rejects sNDA for Sotorasib in KRAS G12C-Mutated NSCLC
Published: October 23rd 2023 | Updated: October 14th 2024
Sotorasib/Panitumumab Combo Improves PFS in Refractory KRAS G12C+ mCRC
Published: January 6th 2023 | Updated: October 14th 2024
Bridging Options for CAR T-Cell Therapy in R/R DLBCL